CK Life Sciences Files Board of Directors List with HKEX

Reuters
11/03
CK Life Sciences Files Board of Directors List with HKEX

CK Life Sciences International (Holdings) Inc. has filed an updated list of directors with the Hong Kong Stock Exchange. The Board is led by Executive Directors LI Tzar Kuoi, Victor (Chairman), KAM Hing Lam (President), IP Tak Chuen, Edmond (Senior Vice President and Chief Investment Officer), YU Ying Choi, Alan Abel (Deputy Chairman), Lance Richard LEE YUEN (Vice President and Chief Executive Officer), and TOH Kean Meng, Melvin (Vice President and Chief Scientific Officer). Non-executive Directors include Peter Peace TULLOCH and Independent Non-executive Directors KWOK Eva Lee, KWAN Kai Cheong, Paul Joseph TIGHE, and Donald Jeffrey ROBERTS. Board committee memberships are as follows: KWAN Kai Cheong chairs the Audit Committee; KWOK Eva Lee chairs the Remuneration Committee and is a member of the Nomination Committee; Paul Joseph TIGHE chairs the Nomination and Sustainability Committees and is a member of the Audit Committee; Donald Jeffrey ROBERTS is a member of the Audit, Remuneration, and Nomination Committees. LI Tzar Kuoi, Victor is a member of the Remuneration and Nomination Committees and chairs the Executive Committee. Other Executive Directors serve as members of the Executive Committee, with IP Tak Chuen, Edmond also serving on the Sustainability Committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CK Life Sciences International (Holdings) Inc. published the original content used to generate this news brief on November 03, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10